<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-SFQYTXAQ</identifier><date>1994</date><creator>Štabuc, Borut</creator><relation>documents/doc/S/URN_NBN_SI_doc-SFQYTXAQ_001.pdf</relation><relation>documents/doc/S/URN_NBN_SI_doc-SFQYTXAQ_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 45-53</format><identifier identifier_type="COBISSID_HOST">118489</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-SFQYTXAQ</identifier><language>slv</language><publisher>Krka</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">Adjuvant therapy</subject><subject language_type_id="eng">Antineoplastic agents</subject><subject language_type_id="eng">Colonic neoplasms</subject><subject language_type_id="eng">Fluorouracil</subject><subject language_type_id="eng">Human</subject><subject language_type_id="slv">Leucovorin</subject><subject language_type_id="slv">Levamisole</subject><subject language_type_id="eng">Perfusion, regional</subject><subject language_type_id="eng">Rectal neoplasms</subject><subject language_type_id="eng">Therapy</subject><title>Sistemsko zdravljenje črevesnega raka</title></Record>